Nasus Pharma Ltd (NSRX)

NYSE · Pharmaceutical Preparations · Inc. L3

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

No signals recorded in the last 12 months.

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-06-17Teleman Dan BenjamindirectorP6,5503.1$20,305
2026-04-22Teleman Dan BenjamindirectorP2,9003.76$10,904
2026-03-31Teleman Dan BenjamindirectorP15,0002.04$30,600

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings